Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 292,129 | 520,875 | 498,925 | 97,416 | 109,643 |
| Marketable Securities | 408,275 | 222,373 | 267,532 | 299,566 | 351,054 |
| Receivables | 32,838 | 32,960 | 18,320 | 10,968 | 20,478 |
| TOTAL | $742,393 | $787,505 | $797,829 | $422,020 | $496,981 |
| Non-Current Assets | |||||
| PPE Net | 64,231 | 58,419 | 58,304 | 49,358 | 47,647 |
| Investments And Advances | 44,089 | 83,010 | 78,222 | 98,710 | 49,985 |
| Other Non-Current Assets | 512 | 1,942 | 1,903 | 3,008 | 3,245 |
| TOTAL | $108,832 | $143,371 | $138,429 | $151,076 | $100,877 |
| Total Assets | $851,225 | $930,876 | $936,258 | $573,096 | $597,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38,289 | 30,314 | 39,232 | 27,872 | 34,905 |
| TOTAL | $223,918 | $285,954 | $283,664 | $96,686 | $104,831 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 200,000 | 200,000 |
| Deferred Revenues | 66,976 | 55,640 | 44,432 | 68,814 | 69,926 |
| TOTAL | $176,310 | $184,319 | $192,327 | $325,013 | $313,691 |
| Total Liabilities | $400,228 | $470,273 | $475,991 | $421,699 | $418,522 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,263 | 79,106 | 78,985 | 66,150 | 66,058 |
| Common Shares | 79 | 79 | 79 | 66 | 66 |
| Retained earnings | -823,294 | -804,835 | -793,217 | -780,146 | -744,308 |
| Other shareholders' equity | -315 | 828 | 170 | -5 | -516 |
| TOTAL | $450,997 | $460,603 | $460,267 | $151,397 | $179,336 |
| Total Liabilities And Equity | $851,225 | $930,876 | $936,258 | $573,096 | $597,858 |